|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 5/02 | |
| C07D 401/12 | |||
| C07D 409/14 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| C07D 417/14 | |||
| C07D 207/16 | |||
| A61K 31/47 | |||
| A61P 31/12 | |||
| C07D 487/04 |
| (11) | Patento numeris | 1713822 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05704764.9 |
| Europos patento paraiškos padavimo data | 2005-01-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-10-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-03-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SE2005/000096 |
| Data | 2005-01-28 |
| (87) | Numeris | WO 2005/073216 |
| Data | 2005-08-11 |
| (30) | Numeris | Data | Šalis |
| 0400199 | 2004-01-30 | SE | |
| 0401288 | 2004-05-19 | SE | |
| 0402562 | 2004-10-22 | SE |
| (72) |
ROSENQUIST, Asa, c/o Medivir AB, SE
THORSTENSSON, Fredrik, c/o IFM Faculty, SE
JOHANSSON, Per-Ola, c/o IFM Faculty, SE
KVARNSTRÖM, Ingemar, c/o IFM Faculty, SE
AYESA, Susana, c/o Medivir AB, SE
CLASSON, Björn, c/o Medivir AB, SE
RAKOS, Lazlo, c/o Medivir AB, SE
SAMUELSSON, Bertil, c/o Medivir AB, SE
|
| (73) |
Medivir AB,
P.O. Box 1086, 141 22 Huddinge,
SE
Tibotec Pharmaceuticals, Eastgate Village Eastgate Little Island, Co Cork, IE |
| (54) | HCV NS-3 SERINE PROTEASE INHIBITORS |
| HCV NS-3 SERINE PROTEASE INHIBITORS |